AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells
about
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cellsPredictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.The IGF-1R/AKT pathway determines cell fate in response to p53.Trans-Plasma Membrane Electron Transport and Ascorbate Efflux by Skeletal Muscle.The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer
P2860
AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@ast
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@en
type
label
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@ast
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@en
prefLabel
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@ast
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@en
P2093
P2860
P356
P1476
AMP-activated Protein Kinase ( ...... trexed-treated Carcinoma Cells
@en
P2093
Catherine M Bell
Richard G Moran
Stuti Agarwal
P2860
P304
27473-27486
P356
10.1074/JBC.M115.665133
P407
P577
2015-09-21T00:00:00Z